| abstract |
COMPOSITION FOR THE TREATMENT OF METABOLIC SYNDROME. The present invention relates to a composition that includes a first agent, selected from the group consisting of an inhibitor of oxidative phosphorylation, an ionophore and an activator of the protein kinase activated by adenosine 5-monophosphate (AMPK); a second agent that has anti-inflammatory activity; and a third agent that has serotonin activity. |